Rainbow Children’s Medicare announced its Q3 results, reporting a profit before tax of ₹976.94 million and earnings per share of ₹7.14. The company’s Nomination and Remuneration Committee also granted 100,000 stock options under its ESOP 2025 plan to eligible employees. Mr. Abrarali Dalal was appointed as Chief Executive Officer with effect from January 20, 2026.
Financial Performance
Rainbow Children’s Medicare reported a total income of ₹4,559.61 million for the quarter ended December 31, 2025 (Q3). The profit before tax stood at ₹976.94 million. Profit after tax reached ₹738.97 million. Basic earnings per share were reported as ₹7.14.
Year-to-Date Financials
The company’s year-to-date total income reached ₹12,819.00 million. The year-to-date profit before tax was ₹2,714.38 million, while profit after tax amounted to ₹2,033.26 million. The year-to-date basic earnings per share stood at ₹19.82.
ESOP 2025 Grant
The Nomination and Remuneration Committee granted 100,000 stock options under the ESOP 2025 to eligible employees. This grant will result in the issuance of 100,000 equity shares. Stock options will vest after a minimum period of 1 year. The exercise price will be determined at a discount of no more than 20%.
Leadership Appointment
Mr. Abrarali Dalal has been appointed as the Chief Executive Officer with effect from January 20, 2026. This appointment follows the Board of Directors’ approval on November 13, 2025, based on the recommendation of the Nomination and Remuneration Committee.
Source: BSE
